Cargando…

Nonthyroidal Illness Syndrome Across the Ages

In conditions of acute illness, patients present with reduced plasma T3 concentrations without a concomitant rise in TSH. In contrast, plasma concentrations of the inactive hormone rT3 increase, whereas plasma concentrations of T4 remain low-normal. This constellation of changes, referred to as nont...

Descripción completa

Detalles Bibliográficos
Autores principales: Langouche, Lies, Jacobs, An, Van den Berghe, Greet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853682/
https://www.ncbi.nlm.nih.gov/pubmed/31745528
http://dx.doi.org/10.1210/js.2019-00325
_version_ 1783470079639289856
author Langouche, Lies
Jacobs, An
Van den Berghe, Greet
author_facet Langouche, Lies
Jacobs, An
Van den Berghe, Greet
author_sort Langouche, Lies
collection PubMed
description In conditions of acute illness, patients present with reduced plasma T3 concentrations without a concomitant rise in TSH. In contrast, plasma concentrations of the inactive hormone rT3 increase, whereas plasma concentrations of T4 remain low-normal. This constellation of changes, referred to as nonthyroidal illness syndrome (NTIS), is present across all ages, from preterm neonates and over-term critically ill infants and children to critically ill adults. Although the severity of illness strongly correlates with the severity of the NTIS phenotype, the causality of this association remains debated, and pathophysiological mechanisms remain incompletely understood. In the acute phase of illness, NTIS appears to be caused predominantly by an increased peripheral inactivation of thyroid hormones, in which reduced nutritional intake plays a role. Current evidence suggests that these acute peripheral changes are part of a beneficial adaptation of the body to reduce expenditure of energy and to activate the innate immune response, which is important for survival. In contrast, in more severely ill and prolonged critically ill patients, an additional central suppression of the thyroid hormone axis alters and further aggravates the NTIS phenotype. Recent studies suggest that this central suppression may not be adaptive. Whether treatment of this central component of NTIS in prolonged critically ill patients, with the use of hypothalamic releasing factors, improves outcome remains to be investigated in large randomized control trials.
format Online
Article
Text
id pubmed-6853682
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-68536822019-11-19 Nonthyroidal Illness Syndrome Across the Ages Langouche, Lies Jacobs, An Van den Berghe, Greet J Endocr Soc Mini-Review In conditions of acute illness, patients present with reduced plasma T3 concentrations without a concomitant rise in TSH. In contrast, plasma concentrations of the inactive hormone rT3 increase, whereas plasma concentrations of T4 remain low-normal. This constellation of changes, referred to as nonthyroidal illness syndrome (NTIS), is present across all ages, from preterm neonates and over-term critically ill infants and children to critically ill adults. Although the severity of illness strongly correlates with the severity of the NTIS phenotype, the causality of this association remains debated, and pathophysiological mechanisms remain incompletely understood. In the acute phase of illness, NTIS appears to be caused predominantly by an increased peripheral inactivation of thyroid hormones, in which reduced nutritional intake plays a role. Current evidence suggests that these acute peripheral changes are part of a beneficial adaptation of the body to reduce expenditure of energy and to activate the innate immune response, which is important for survival. In contrast, in more severely ill and prolonged critically ill patients, an additional central suppression of the thyroid hormone axis alters and further aggravates the NTIS phenotype. Recent studies suggest that this central suppression may not be adaptive. Whether treatment of this central component of NTIS in prolonged critically ill patients, with the use of hypothalamic releasing factors, improves outcome remains to be investigated in large randomized control trials. Endocrine Society 2019-10-16 /pmc/articles/PMC6853682/ /pubmed/31745528 http://dx.doi.org/10.1210/js.2019-00325 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Review
Langouche, Lies
Jacobs, An
Van den Berghe, Greet
Nonthyroidal Illness Syndrome Across the Ages
title Nonthyroidal Illness Syndrome Across the Ages
title_full Nonthyroidal Illness Syndrome Across the Ages
title_fullStr Nonthyroidal Illness Syndrome Across the Ages
title_full_unstemmed Nonthyroidal Illness Syndrome Across the Ages
title_short Nonthyroidal Illness Syndrome Across the Ages
title_sort nonthyroidal illness syndrome across the ages
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853682/
https://www.ncbi.nlm.nih.gov/pubmed/31745528
http://dx.doi.org/10.1210/js.2019-00325
work_keys_str_mv AT langouchelies nonthyroidalillnesssyndromeacrosstheages
AT jacobsan nonthyroidalillnesssyndromeacrosstheages
AT vandenberghegreet nonthyroidalillnesssyndromeacrosstheages